<?xml version="1.0" encoding="us-ascii"?><inf:proxyVoteTable xmlns:inf="http://www.sec.gov/edgar/document/npxproxy/informationtable">
<!--VoteTableSchemaVersion:X0300-->
<inf:proxyTable><inf:issuerName>ADVANTAGE SOLUTIONS INC.</inf:issuerName><inf:cusip>00791N102</inf:cusip><inf:isin>US00791N1028</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To approve, on a advisory (non-binding) basis, the compensation of Advantage Solution Inc.'s named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>980865</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>980865</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BLACKBAUD, INC.</inf:issuerName><inf:cusip>09227Q100</inf:cusip><inf:isin>US09227Q1004</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>ADVISORY VOTE TO APPROVE THE 2024 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>193000</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>193000</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EQUITY COMMONWEALTH</inf:issuerName><inf:cusip>294628102</inf:cusip><inf:isin>US2946281027</inf:isin><inf:meetingDate>11/12/2024</inf:meetingDate><inf:voteDescription>To approve, on an advisory, non-binding basis, the compensation that may become payable by the Company to its named executive officers in connection with the Plan of Sale.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4700000</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>4700000</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ESPERION THERAPEUTICS, INC.</inf:issuerName><inf:cusip>29664W105</inf:cusip><inf:isin>US29664W1053</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>To approve the non-binding advisory resolution on the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>3000000</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>3000000</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote></inf:proxyTable>
</inf:proxyVoteTable>